European Pharmaceutical Review

AUGUST 23, 2022

The researchers studied 254 VA patients who were diagnosed with PTSD and hepatitis C between October 1999 and September 2019. Many people have PTSD, but there [are] few effective pharmacologic treatments and limited drug development for PTSD,” commented Gradus. The post Can Hepatitis C drugs reduce symptoms of PTSD?

Food and Drug Administration 94

Food and Drug Administration Pharmacology Prospecting Medical 94

Clarivate

SEPTEMBER 11, 2024

Personalized care relies on pharmacological and non-pharmacological interventions aimed at (temporarily) relieving cognitive and non-cognitive symptoms (Alzheimer’s Association, n.d.; Currently, of the eight drugs approved by the U.S. Food and Drug Administration, 2023 and 2024). 2024; Quanterix, 2024).

Food and Drug Administration 59

Food and Drug Administration Pharmacology Food FDA 59

MedCity News

JUNE 16, 2023

Investors in 2022 appeared confident that the continued transformation of drug research and development protocols and the overall life sciences industry will not only include digital health solutions, but will even depend on them for data collection, analysis, patient engagement, and even their therapeutic properties.

Pharma 110

Pharma Food and Drug Administration Recruitment Patients 110

European Pharmaceutical Review

SEPTEMBER 22, 2023

Limitations of monoclonal antibody therapies Regulatory approvals from the US Food and Drug Administration (FDA) for aducanumab and lecanemab – and likely very soon for donanemab also – opened a route for different therapeutic modalities and other relevant disease targets, such as tau.

Food and Drug Administration 97

Food and Drug Administration Safety Patients Leads 97